|
GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
|
US5102904A
(en)
|
1989-12-08 |
1992-04-07 |
American Cyanamid Company |
N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas
|
|
EP1411933A1
(en)
*
|
2001-08-03 |
2004-04-28 |
SmithKline Beecham Corporation |
Alpha-ketoamide derivatives as cathepsin k inhibitors
|
|
WO2004021979A2
(en)
|
2002-09-06 |
2004-03-18 |
Smithkline Beecham Corporation |
PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
|
|
JP4842929B2
(ja)
|
2004-05-27 |
2011-12-21 |
ファイザー・プロダクツ・インク |
癌治療に有用なピロロピリミジン誘導体
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
EP1913000B1
(en)
|
2005-07-29 |
2012-01-11 |
Pfizer Products Inc. |
Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
CN2928286Y
(zh)
|
2006-01-06 |
2007-08-01 |
水城钢铁（集团）有限责任公司 |
预入口导卫装置
|
|
KR101450535B1
(ko)
|
2006-02-02 |
2014-10-14 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Ｅ１ 활성화 효소의 억제제
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
KR20150036210A
(ko)
|
2007-06-13 |
2015-04-07 |
인사이트 코포레이션 |
야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
WO2009016460A2
(en)
|
2007-08-01 |
2009-02-05 |
Pfizer Inc. |
Pyrazole compounds and their use as raf inhibitors
|
|
UA104849C2
(uk)
|
2007-11-16 |
2014-03-25 |
Інсайт Корпорейшн |
4-піразоліл-n-арилпіримідин-2-аміни і 4-піразоліл-n-гетероарилпіримідин-2-аміни як інгібітори кіназ janus
|
|
HUE029767T2
(en)
*
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
TWI720517B
(zh)
|
2009-01-15 |
2021-03-01 |
美商英塞特公司 |
製造ｊａｋ抑制劑之方法及相關中間化合物
|
|
JP2012523405A
(ja)
|
2009-04-10 |
2012-10-04 |
ファイザー・インク |
４，５−ジヒドロ−１ｈ−ピラゾール化合物およびその薬学的使用
|
|
AR076794A1
(es)
|
2009-05-22 |
2011-07-06 |
Incyte Corp |
Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
|
|
SI2432472T1
(sl)
|
2009-05-22 |
2019-11-29 |
Incyte Holdings Corp |
3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
|
CN106220623A
(zh)
|
2009-11-06 |
2016-12-14 |
普莱希科公司 |
用于激酶调节的化合物和方法及其适应症
|
|
ES2627911T3
(es)
|
2009-11-18 |
2017-08-01 |
Plexxikon, Inc. |
Derivados de N-[2-fluoro-3-(4-amino-7H-pirrolo[2,3-d]pirimidin-5-carbonil)-fenil]-4-bencenosulfonamida como moduladores de la proteína quinasa Raf para el tratamiento del cáncer
|
|
JP5858434B2
(ja)
|
2010-02-18 |
2016-02-10 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｎｕｓキナーゼ阻害薬としてのシクロブタンおよびメチルシクロブタン誘導体
|
|
EP3354652B1
(en)
|
2010-03-10 |
2020-05-06 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
PE20130216A1
(es)
|
2010-05-21 |
2013-02-27 |
Incyte Corp |
Formulacion topica para un inhibidor de jak
|
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
|
PE20140146A1
(es)
|
2010-11-19 |
2014-02-06 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
CN103797010B
(zh)
|
2011-06-20 |
2016-02-24 |
因塞特控股公司 |
作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
|
|
AU2012295802B2
(en)
|
2011-08-12 |
2017-03-30 |
Nissan Chemical Industries, Ltd. |
Tricyclic heterocyclic compounds and JAK inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
EP2628730B1
(en)
|
2012-02-16 |
2017-12-06 |
Noxell Corporation |
Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
PH12020551186B1
(en)
|
2012-11-15 |
2024-03-20 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
|
CN103044286B
(zh)
*
|
2013-01-25 |
2015-04-08 |
重庆紫光化工股份有限公司 |
丙二腈的合成方法
|
|
RS62867B1
(sr)
|
2013-03-06 |
2022-02-28 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
|
HUE033587T2
(hu)
|
2013-05-17 |
2017-12-28 |
Incyte Corp |
Bipirazol-származékok mint JAK inhibitorok
|
|
SMT202000315T1
(it)
|
2013-08-07 |
2020-07-08 |
Incyte Corp |
Forme di dosaggio a rilascio prolungato per un inibitore di jak1
|
|
MA39987A
(fr)
|
2014-04-30 |
2017-03-08 |
Incyte Corp |
Procédés de préparation d'un inhibiteur de jak1 et nouvelles formes associées
|
|
EP3183253B1
(en)
|
2014-08-21 |
2018-06-27 |
ratiopharm GmbH |
Salt of (r)-3-(4-(7h-pyrrolo [2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid
|
|
EP3183252B1
(en)
|
2014-08-21 |
2021-05-12 |
ratiopharm GmbH |
Oxalate salt of ruxolitinib
|
|
WO2016035014A1
(en)
|
2014-09-01 |
2016-03-10 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of ruxolitinib phosphate
|
|
WO2016063294A2
(en)
|
2014-10-20 |
2016-04-28 |
Msn Laboratories Private Limited |
Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
|
|
JP6038111B2
(ja)
*
|
2014-12-27 |
2016-12-07 |
ヤマサ醤油株式会社 |
多置換７−デアザプリン誘導体合成のための２，６−ジクロロ−８−ヨード−７−デアザプリン
|
|
MX2017010844A
(es)
|
2015-02-24 |
2017-12-07 |
Pfizer |
Derivados de nucleosidos sustituidos utiles como agentes anticancerosos.
|
|
CA2928286A1
(en)
|
2015-04-28 |
2016-10-28 |
Signa S.A. De C.V. |
Solid form of ruxolitinib phosphate
|
|
CN106397443A
(zh)
|
2015-07-17 |
2017-02-15 |
浙江九洲药业股份有限公司 |
一种吡咯嘧啶类衍生物中间体的制备方法
|
|
CZ2015575A3
(cs)
|
2015-08-26 |
2017-03-08 |
Zentiva, K.S. |
Soli 5-fluoro-3-fenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-onu a jejich příprava
|
|
EP3394080B1
(en)
|
2015-12-23 |
2023-06-07 |
The University Of British Columbia |
Lipid-linked prodrugs
|
|
US10562904B2
(en)
|
2015-12-31 |
2020-02-18 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Synthesis process of ruxolitinib
|
|
CZ201629A3
(cs)
|
2016-01-22 |
2017-08-02 |
Zentiva, K.S. |
Krystalické modifikace solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a způsoby jejich přípravy
|
|
CN107513069A
(zh)
|
2016-06-16 |
2017-12-26 |
正大天晴药业集团股份有限公司 |
手性吡咯并嘧啶化合物的制备方法
|
|
IN201641026603A
(https=)
|
2016-08-04 |
2018-02-09 |
|
|
|
CN107722012B
(zh)
|
2016-08-11 |
2020-05-29 |
斯福瑞（南通）制药有限公司 |
制备4-氯-7H-吡咯并[2,3-d]嘧啶的方法
|
|
CN107759601B
(zh)
|
2016-08-23 |
2020-09-11 |
苏州旺山旺水生物医药有限公司 |
一种jak抑制剂及其盐的制备方法
|
|
CN107759623B
(zh)
|
2016-08-23 |
2020-08-14 |
苏州旺山旺水生物医药有限公司 |
Jak抑制剂的中间体及其制备方法
|
|
US20190263796A1
(en)
|
2016-09-23 |
2019-08-29 |
Cellipse |
Lim kinase inhibitors, pharmaceutical composition and method of use in limk-mediated diseases
|
|
CN109651424B
(zh)
|
2017-10-11 |
2021-01-22 |
新发药业有限公司 |
一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-d]嘧啶的合成方法
|
|
CN113149993A
(zh)
|
2017-12-01 |
2021-07-23 |
北京普祺医药科技有限公司 |
一种吡咯并嘧啶衍生的化合物、药物组合物以及其用途
|
|
US10766900B2
(en)
|
2017-12-29 |
2020-09-08 |
Formosa Laboratories, Inc. |
Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
|
|
SG11202007164UA
(en)
|
2018-01-30 |
2020-08-28 |
Incyte Corp |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
CN112041303A
(zh)
|
2018-05-21 |
2020-12-04 |
Pi工业有限公司 |
制备取代的杂环化合物的方法
|
|
AU2020219797B2
(en)
|
2019-02-06 |
2025-10-16 |
Sun Pharmaceutical Industries, Inc. |
Process for preparing enantiomerically enriched jak inhibitors
|
|
CN110724145A
(zh)
|
2019-11-01 |
2020-01-24 |
廖文杰 |
一种医药中间体4-氯吡咯并嘧啶的合成方法
|
|
CN116761792A
(zh)
*
|
2020-08-18 |
2023-09-15 |
因赛特公司 |
用于制备jak抑制剂的方法和中间体
|
|
IL300557A
(en)
|
2020-08-18 |
2023-04-01 |
Incyte Corp |
Process and intermediates for preparing a JAK1 inhibitor
|
|
PE20231743A1
(es)
|
2020-08-18 |
2023-10-31 |
Incyte Corp |
Proceso e intermediarios para preparar un inhibidor de jak
|
|
US12071439B2
(en)
|
2021-07-12 |
2024-08-27 |
Incyte Corporation |
Process and intermediates for preparing a JAK inhibitor
|
|
CN113480546A
(zh)
|
2021-07-30 |
2021-10-08 |
江苏君若药业有限公司 |
巴瑞克替尼及其衍生物的制备
|